Your browser doesn't support javascript.
loading
Machine learning-based prediction of in-hospital death for patients with takotsubo syndrome: The InterTAK-ML model.
De Filippo, Ovidio; Cammann, Victoria L; Pancotti, Corrado; Di Vece, Davide; Silverio, Angelo; Schweiger, Victor; Niederseer, David; Szawan, Konrad A; Würdinger, Michael; Koleva, Iva; Dusi, Veronica; Bellino, Michele; Vecchione, Carmine; Parodi, Guido; Bossone, Eduardo; Gili, Sebastiano; Neuhaus, Michael; Franke, Jennifer; Meder, Benjamin; Jaguszewski, Milosz; Noutsias, Michel; Knorr, Maike; Jansen, Thomas; Dichtl, Wolfgang; von Lewinski, Dirk; Burgdorf, Christof; Kherad, Behrouz; Tschöpe, Carsten; Sarcon, Annahita; Shinbane, Jerold; Rajan, Lawrence; Michels, Guido; Pfister, Roman; Cuneo, Alessandro; Jacobshagen, Claudius; Karakas, Mahir; Koenig, Wolfgang; Pott, Alexander; Meyer, Philippe; Roffi, Marco; Banning, Adrian; Wolfrum, Mathias; Cuculi, Florim; Kobza, Richard; Fischer, Thomas A; Vasankari, Tuija; Airaksinen, K E Juhani; Napp, L Christian; Dworakowski, Rafal; MacCarthy, Philip.
Afiliación
  • De Filippo O; Division of Cardiology, Department of Medical Sciences, AOU Città della Salute e della Scienza, University of Turin, Turin, Italy.
  • Cammann VL; Department of Cardiology, University Heart Center, University Hospital Zurich, and University of Zurich, Zurich, Switzerland.
  • Pancotti C; Department of Medical Sciences, University of Turin, Turin, Italy.
  • Di Vece D; Department of Cardiology, University Heart Center, University Hospital Zurich, and University of Zurich, Zurich, Switzerland.
  • Silverio A; Department of Medicine, Surgery and Dentistry, University of Salerno, Baronissi, Italy.
  • Schweiger V; Department of Cardiology, University Heart Center, University Hospital Zurich, and University of Zurich, Zurich, Switzerland.
  • Niederseer D; Department of Cardiology, University Heart Center, University Hospital Zurich, and University of Zurich, Zurich, Switzerland.
  • Szawan KA; Department of Cardiology, University Heart Center, University Hospital Zurich, and University of Zurich, Zurich, Switzerland.
  • Würdinger M; Department of Cardiology, University Heart Center, University Hospital Zurich, and University of Zurich, Zurich, Switzerland.
  • Koleva I; Department of Cardiology, University Heart Center, University Hospital Zurich, and University of Zurich, Zurich, Switzerland.
  • Dusi V; Division of Cardiology, Department of Medical Sciences, AOU Città della Salute e della Scienza, University of Turin, Turin, Italy.
  • Bellino M; Department of Medicine, Surgery and Dentistry, University of Salerno, Baronissi, Italy.
  • Vecchione C; Department of Medicine, Surgery and Dentistry, University of Salerno, Baronissi, Italy.
  • Parodi G; Department of Vascular Physiopathology, IRCCS Neuromed, Pozzilli, Italy.
  • Bossone E; Department of Medicine, Surgery and Pharmacy, University of Sassari, Sassari, Italy.
  • Gili S; Division of Cardiology, 'Antonio Cardarelli' Hospital, Naples, Italy.
  • Neuhaus M; Centro Cardiologico Monzino, IRCCS, Milan, Italy.
  • Franke J; Department of Cardiology, Kantonsspital Frauenfeld, Frauenfeld, Switzerland.
  • Meder B; Department of Cardiology, Heidelberg University Hospital, Heidelberg, Germany.
  • Jaguszewski M; Department of Cardiology, Heidelberg University Hospital, Heidelberg, Germany.
  • Noutsias M; First Department of Cardiology, Medical University of Gdansk, Gdansk, Poland.
  • Knorr M; Division of Cardiology, Angiology and Intensive Medical Care, Department of Internal Medicine III, Mid-German Heart Center, University Hospital Halle, Martin-Luther-University Halle-Wittenberg, Halle (Saale), Germany.
  • Jansen T; Center for Cardiology, Cardiology 1, University Medical Center Mainz, Mainz, Germany.
  • Dichtl W; Center for Cardiology, Cardiology 1, University Medical Center Mainz, Mainz, Germany.
  • von Lewinski D; University Hospital for Internal Medicine III (Cardiology and Angiology), Medical University Innsbruck, Innsbruck, Austria.
  • Burgdorf C; Division of Cardiology, Medical University of Graz, Graz, Austria.
  • Kherad B; Heart and Vascular Centre Bad Bevensen, Bad Bevensen, Germany.
  • Tschöpe C; Department of Cardiology, Charité, Campus Rudolf Virchow, Berlin, Germany.
  • Sarcon A; Department of Cardiology, Charité, Campus Rudolf Virchow, Berlin, Germany.
  • Shinbane J; Section of Cardiac Electrophysiology, Department of Medicine, University of California, San Francisco, San Francisco, CA, USA.
  • Rajan L; Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
  • Michels G; TJ Health Partners Heart and Vascular, Glasgow, KY, USA.
  • Pfister R; Klinik für Akut- und Notfallmedizin, St.-Antonius-Hospital gGmbH, Akademisches Lehrkrankenhaus der RWTH Aachen, Eschweiler, Germany.
  • Cuneo A; Department of Internal Medicine III, Heart Center University of Cologne, Cologne, Germany.
  • Jacobshagen C; Krankenhaus 'Maria Hilf' Medizinische Klinik, Stadtlohn, Germany.
  • Karakas M; Clinic for Cardiology and Pneumology, Georg August University Goettingen, Goettingen, Germany.
  • Koenig W; Vincentius-Diakonissen Hospital, Karlsruhe, Germany.
  • Pott A; Department of Intensive Care Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Meyer P; DZHK (German Centre for Cardiovascular Research), Partner Site Hamburg/Kiel/Luebeck, Hamburg, Germany.
  • Roffi M; Deutsches Herzzentrum München, Technische Universität München, Munich, Germany.
  • Banning A; DZHK (German Centre for Cardiovascular Research), Partner Site Munich Heart Alliance, Munich, Germany.
  • Wolfrum M; Department of Internal Medicine II-Cardiology, Medical Center, University of Ulm, Ulm, Germany.
  • Cuculi F; Service de Cardiologie, Hôpitaux Universitaires de Genève, Geneva, Switzerland.
  • Kobza R; Service de Cardiologie, Hôpitaux Universitaires de Genève, Geneva, Switzerland.
  • Fischer TA; Department of Cardiology, John Radcliffe Hospital, Oxford University Hospitals, Oxford, UK.
  • Vasankari T; Department of Cardiology, Kantonsspital Lucerne, Lucerne, Switzerland.
  • Airaksinen KEJ; Department of Cardiology, Kantonsspital Lucerne, Lucerne, Switzerland.
  • Napp LC; Department of Cardiology, Kantonsspital Lucerne, Lucerne, Switzerland.
  • Dworakowski R; Department of Cardiology, Kantonsspital Winterthur, Winterthur, Switzerland.
  • MacCarthy P; Heart Center, Turku University Hospital, University of Turku, Turku, Finland.
Eur J Heart Fail ; 25(12): 2299-2311, 2023 Dec.
Article en En | MEDLINE | ID: mdl-37522520
ABSTRACT

AIMS:

Takotsubo syndrome (TTS) is associated with a substantial rate of adverse events. We sought to design a machine learning (ML)-based model to predict the risk of in-hospital death and to perform a clustering of TTS patients to identify different risk profiles. METHODS AND

RESULTS:

A ridge logistic regression-based ML model for predicting in-hospital death was developed on 3482 TTS patients from the International Takotsubo (InterTAK) Registry, randomly split in a train and an internal validation cohort (75% and 25% of the sample size, respectively) and evaluated in an external validation cohort (1037 patients). Thirty-one clinically relevant variables were included in the prediction model. Model performance represented the primary endpoint and was assessed according to area under the curve (AUC), sensitivity and specificity. As secondary endpoint, a K-medoids clustering algorithm was designed to stratify patients into phenotypic groups based on the 10 most relevant features emerging from the main model. The overall incidence of in-hospital death was 5.2%. The InterTAK-ML model showed an AUC of 0.89 (0.85-0.92), a sensitivity of 0.85 (0.78-0.95) and a specificity of 0.76 (0.74-0.79) in the internal validation cohort and an AUC of 0.82 (0.73-0.91), a sensitivity of 0.74 (0.61-0.87) and a specificity of 0.79 (0.77-0.81) in the external cohort for in-hospital death prediction. By exploiting the 10 variables showing the highest feature importance, TTS patients were clustered into six groups associated with different risks of in-hospital death (28.8% vs. 15.5% vs. 5.4% vs. 1.0.8% vs. 0.5%) which were consistent also in the external cohort.

CONCLUSION:

A ML-based approach for the identification of TTS patients at risk of adverse short-term prognosis is feasible and effective. The InterTAK-ML model showed unprecedented discriminative capability for the prediction of in-hospital death.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Cardiomiopatía de Takotsubo / Insuficiencia Cardíaca Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Eur J Heart Fail Asunto de la revista: CARDIOLOGIA Año: 2023 Tipo del documento: Article País de afiliación: Italia

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Cardiomiopatía de Takotsubo / Insuficiencia Cardíaca Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Eur J Heart Fail Asunto de la revista: CARDIOLOGIA Año: 2023 Tipo del documento: Article País de afiliación: Italia